The food intake-suppressive effects of glucagon-like peptide-1 receptor signaling in the ventral tegmental area are mediated by AMPA/kainate receptors

American Journal of Physiology - Endocrinology and Metabolism

Volumn 305, Issue 11, 2013, Pages

  Mietlicki Baase, Elizabeth G ^a   Ortinski, Pavel I ^a   Rupprecht, Laura E ^a   Olivos, Diana R ^a   Alhadeff, Amber L ^a   Christopher Pierce, R ^a   Hayes, Matthew R ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

2 amino 3 hydroxy 5 methyl 4 isoxazol propionic acid; Diabetes; Dopamine; Glucagon like peptide 1; Glutamate; Obesity; Reward

Indexed keywords

AMPA RECEPTOR; EXENDIN 4; GLUCAGON LIKE PEPTIDE 1 RECEPTOR; KAINIC ACID RECEPTOR; TYROSINE 3 MONOOXYGENASE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; DOPAMINERGIC SYSTEM; FOOD INTAKE; LIPID DIET; MALE; MEAL; NERVE ENDING; NONHUMAN; PALATABILITY; PRESYNAPTIC MEMBRANE; PRIORITY JOURNAL; RAT; SATIETY; SIGNAL TRANSDUCTION; VENTRAL TEGMENTUM; WEIGHT GAIN;

2-AMINO-3-HYDROXY-5-METHYL-4-ISOXAZOL PROPIONIC ACID; DIABETES; DOPAMINE; GLUCAGON-LIKE PEPTIDE-1; GLUTAMATE; OBESITY; REWARD;

ANIMALS; APPETITE DEPRESSANTS; APPETITE REGULATION; DIET, HIGH-FAT; FEEDING BEHAVIOR; GLUCAGON-LIKE PEPTIDE 1; MALE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, AMPA; RECEPTORS, GLUCAGON; RECEPTORS, KAINIC ACID; REWARD; SIGNAL TRANSDUCTION; VENTRAL TEGMENTAL AREA;

EID: 84888860281     PISSN: 01931849     EISSN: 15221555     Source Type: Journal    
DOI: 10.1152/ajpendo.00413.2013     Document Type: Article

References (36)

1. Acuna-Goycolea C, van den Pol A. Glucagon-like peptide 1 excites hypocretin/orexin neurons by direct and indirect mechanisms: implications for viscera-mediated arousal. J Neurosci 24: 8141-8152, 2004.
2. Adell A, Artigas F. The somatodendritic release of dopamine in the ventral tegmental area and its regulation by afferent transmitter systems. Neurosci Biobehav Rev 28: 415-431, 2004.
3. Alhadeff AL, Rupprecht LE, Hayes MR. GLP-1 neurons in the nucleus of the solitary tract project directly to the ventral tegmental area and nucleus accumbens to control for food intake. Endocrinology 153: 647-658, 2012.
4. Astrup A, Rossner S, Van Gaal L, Rissanen A, Niskanen L, Al Hakim M, Madsen J, Rasmussen MF, Lean ME. Effects of liraglutide in the treatment of obesity: a randomised, double-blind, placebo-controlled study. Lancet 374: 1606-1616, 2009.
5. Barbano MF, Le Saux M, Cador M. Involvement of dopamine and opioids in the motivation to eat: influence of palatability, homeostatic state, and behavioral paradigms. Psychopharmacology 203: 475-487, 2009.
6. Berthoud HR. Vagal and hormonal gut-brain communication: from satiation to satisfaction. Neurogastroenterol Motil 20, Suppl 1: 64-72, 2008.
7. Brown HD, McCutcheon JE, Cone JJ, Ragozzino ME, Roitman MF. Primary food reward and reward-predictive stimuli evoke different patterns of phasic dopamine signaling throughout the striatum. Eur J Neurosci 34: 1997-2006, 2011.
8. Burns GA, Ritter RC. The non-competitive NMDA antagonist MK-801 increases food intake in rats. Pharmacol Biochem Behav 56: 145-149, 1997.
9. Buse JB, Rosenstock J, Sesti G, Schmidt WE, Montanya E, Brett JH, Zychma M, Blonde L. Liraglutide once a day versus exenatide twice a day for type 2 diabetes: a 26-week randomised, parallel-group, multinational, open-label trial (LEAD-6). Lancet 374: 39-47, 2009.
10. Chieng B, Azriel Y, Mohammadi S, Christie MJ. Distinct cellular properties of identified dopaminergic and GABAergic neurons in the mouse ventral tegmental area. J Physiol 589: 3775-3787, 2011.
11. Covasa M, Hung CY, Ritter RC, Burns GA. Intracerebroventricular administration of MK-801 increases food intake through mechanisms independent of gastric emptying. Am J Physiol Regul Integr Comp Physiol 287: R1462-R1467, 2004.
12. Davidson MB, Bate G, Kirkpatrick P. Exenatide. Nat Rev Drug Discov 4: 713-714, 2005.
13. Dickson SL, Shirazi RH, Hansson C, Bergquist F, Nissbrandt H, Skibicka KP. The glucagon-like peptide 1 (GLP-1) analogue, exendin-4, decreases the rewarding value of food: a new role for mesolimbic GLP-1 receptors. J Neurosci 32: 4812-4820, 2012.
14. Dossat AM, Lilly N, Kay K, Williams DL. Glucagon-like peptide 1 receptors in nucleus accumbens affect food intake. J Neurosci 31: 14453-14457, 2011.
15. Ford CP, Mark GP, Williams JT. Properties and opioid inhibition of mesolimbic dopamine neurons vary according to target location. J Neurosci 26: 2788-2797, 2006.
16. Geisler S, Wise RA. Functional implications of glutamatergic projections to the ventral tegmental area. Rev Neurosci 19: 227-244, 2008.
17. Gillespie BR, Burns GA, Ritter RC. NMDA channels control meal size via central vagal afferent terminals. Am J Physiol Regul Integr Comp Physiol 289: R1504-R1511, 2005.
18. Grigson PS, Hajnal A. Once is too much: conditioned changes in accumbens dopamine following a single saccharin-morphine pairing. Behav Neurosci 121: 1234-1242, 2007.
19. Hayes MR. Neuronal and intracellular signaling pathways mediating GLP-1 energy balance and glycemic effects. Physiol Behav 106: 413-416, 2012.
20. Hayes MR, Leichner TM, Zhao S, Lee GS, Chowansky A, Zimmer D, De Jonghe BC, Kanoski SE, Grill HJ, Bence KK. Intracellular signals mediating the food intake-suppressive effects of hindbrain glucagon-like peptide-1 receptor activation. Cell Metab 13: 320-330, 2011.
21. Hayes MR, Skibicka KP, Grill HJ. Caudal brainstem processing is sufficient for behavioral, sympathetic, and parasympathetic responses driven by peripheral and hindbrain glucagon-like-peptide-1 receptor stimulation. Endocrinology 149: 4059-4068, 2008.
22. Hettes SR, Gonzaga J, Heyming TW, Perez S, Wolfsohn S, Stanley BG. Dual roles in feeding for AMPA/kainate receptors: receptor activation or inactivation within distinct hypothalamic regions elicits feeding behavior. Brain Res 992: 167-178, 2003.
23. Holst JJ. The physiology of glucagon-like peptide 1. Physiol Rev 87: 1409-1439, 2007.
24. Kanoski SE, Fortin SM, Arnold M, Grill HJ, Hayes MR. Peripheral and central GLP-1 receptor populations mediate the anorectic effects of peripherally administered GLP-1 receptor agonists, liraglutide and exendin-4. Endocrinology 152: 3103-3112, 2011.
25. Kanoski SE, Rupprecht LE, Fortin SM, De Jonghe BC, Hayes MR. The role of nausea in food intake and body weight suppression by peripheral GLP-1 receptor agonists, exendin-4 and liraglutide. Neuropharmacology 62: 1916-1927, 2012.
26. Kinzig KP, D'Alessio DA, Seeley RJ. The diverse roles of specific GLP-1 receptors in the control of food intake and the response to visceral illness. J Neurosci 22: 10470-10476, 2002.
27. Maldonado-Irizarry CS, Swanson CJ, Kelley AE. Glutamate receptors in the nucleus accumbens shell control feeding behavior via the lateral hypothalamus. J Neurosci 15: 6779-6788, 1995.
28. Narayanan NS, Guarnieri DJ, DiLeone RJ. Metabolic hormones, dopamine circuits, and feeding. Front Neuroendocrinol 31: 104-112, 2010.
29. Omelchenko N, Bell R, Sesack SR. Lateral habenula projections to dopamine and GABA neurons in the rat ventral tegmental area. Eur J Neurosci 30: 1239-1250, 2009.
30. Paxinos G, Watson C. The Rat Brain in Stereotaxic Coordinates. Burlington, MA: Elsevier Academic, 2005.
31. Roitman MF, Stuber GD, Phillips PE, Wightman RM, Carelli RM. Dopamine operates as a subsecond modulator of food seeking. J Neurosci 24: 1265-1271, 2004.
32. Schmidt HD, Famous KR, Pierce RC. The limbic circuitry underlying cocaine seeking encompasses the PPTg/LDT. Eur J Neurosci 30: 1358-1369, 2009.
33. Turton MD, O'Shea D, Gunn I, Beak SA, Edwards CM, Meeran K, Choi SJ, Taylor GM, Heath MM, Lambert PD, Wilding JP, Smith DM, Ghatei MA, Herbert J, Bloom SR. A role for glucagon-like peptide-1 in the central regulation of feeding. Nature 379: 69-72, 1996.
34. Vrang N, Phifer CB, Corkern MM, Berthoud HR. Gastric distension induces c-Fos in medullary GLP-1/2-containing neurons. Am J Physiol Regul Integr Comp Physiol 285: R470-R478, 2003.
35. Vucetic Z, Reyes TM. Central dopaminergic circuitry controlling food intake and reward: implications for the regulation of obesity. Wiley Interdiscip Rev Syst Biol Med 2: 577-593, 2010.
36. Wanat MJ, Willuhn I, Clark JJ, Phillips PE. Phasic dopamine release in appetitive behaviors and drug addiction. Curr Drug Abuse Rev 2: 195-213, 2009.